Tuesday 3 May 2016
 
»
Tag
 
»
Pfizer

Obama's inversion curbs kill Pfizer's $160bn Allergan deal

US drug maker Pfizer Inc agreed on Tuesday to terminate its $160 billion agreement to acquire Botox maker Allergan Plc, in a major victory to US President Barack Obama's drive to stop tax-dodging corporate mergers. The decisio

More…

Pfizer, Allergan to terminate merger

Drugmakers Pfizer Inc and Allergan Plc will mutually terminate their merger early Wednesday morning, according to a source familiar with the matter. Earlier on Tuesday, Reuters reported that Pfizer was leaning towards abandoning i

More…

Pfizer to buy Allergan in $160bn deal

Pfizer, the maker of Viagra and Lipitor, has struck a deal to buy Botox-maker Allergan in a transaction valued at about $160 billion, creating the world's biggest drugmaker. New York-based Pfizer and Allergan, headquartered in

More…

Pfizer to buy Allergan in $160bn deal

Pfizer, the maker of Viagra and Lipitor, has struck a deal to buy Botox-maker Allergan in a transaction valued at about $160 billion, creating the world's biggest drugmaker. New York-based Pfizer and Allergan, headquartered in

More…

Pfizer set to buy Botox maker Allergan for $150bn

Pfizer was due to secure formal board approval on Sunday for its acquisition of Botox maker Allergan for more than $150 billion, making it the healthcare sector's largest deal ever, according to people familiar with the matter.

More…

Pfizer in talks with Allergan to forge $330bn drugs giant

Pharmaceutical giant Pfizer Inc has held early talks with Botox-maker Allergan to discuss what could be the biggest takeover deal this year, the Wall Street Journal and Financial Times reported. The healthcare sector has seen an u

More…

Merck, Pfizer collaborate with Dako to develop avelumab

Merck and Pfizer have signed a collaboration agreement with Dako, an Agilent Technology company, for the development of a potential companion diagnostic test (CDx), as part of a global strategic alliance to jointly develop and commercialise av

More…

Merck and Pfizer to present updates for avelumab

Merck and Pfizer is set to present six six abstracts on studies evaluating the potential role of programmed death-ligand 1 (PD-L1) inhibition and the safety and efficacy of the investigational cancer immunotherapy avelumab at an upcoming event

More…

Paying for gene therapy: Annuities the next big thing?

As US drugmakers face growing resistance to the high price of cutting-edge treatments, a handful of companies are working on a new payment model that rewards them for the long-term performance of their medicines. The effort, indus

More…

Pfizer ends $118bn AstraZeneca takeover fight

Pfizer abandoned its attempt to buy AstraZeneca for nearly 70 billion pounds ($118 billion) on Monday as a deadline approached without a last-minute change of heart by the British drugmaker. The decision ends a month-long public f

More…
 1 2 3 4 5 >  Last ›

calendarCalendar of Events

Ads